The U.S. EPA officially acknowledged in its internal cancer assessment that trifludimoxazin carries 'suggestive evidence of carcinogenic potential' before approving it on Tuesday 1 July 2026. Yet the agency concluded exposure limits would protect against cancer risk despite the cancer evidence found in its scientific review.
The EPA Environmental Protection Agency approved three new pesticides because they technically fall outside its own PFAS definition. U.S. EPA pesticide registration records confirm the pesticides contain 'single-fluorinated-carbon compounds' that avoid the 2023 requirement for 'two or more fluorinated carbons' to classify as PFAS.
